These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2554803)

  • 1. Antagonism of the cytotoxic but not antiviral effects of ara-sangivamycin by adenosine.
    Birch GM; Krawczyk SH; Townsend LB; Drach JC
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1606-8. PubMed ID: 2554803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrrolo[2,3-d]pyrimidine nucleosides as inhibitors of human cytomegalovirus.
    Turk SR; Shipman C; Nassiri R; Genzlinger G; Krawczyk SH; Townsend LB; Drach JC
    Antimicrob Agents Chemother; 1987 Apr; 31(4):544-50. PubMed ID: 3037998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antiviral activity of some 7-[(2-hydroxyethoxy)methyl]pyrazolo[3,4-d]pyrimidine analogues of sangivamycin and toyocamycin.
    Saxena NK; Coleman LA; Drach JC; Townsend LB
    J Med Chem; 1990 Jul; 33(7):1980-3. PubMed ID: 2163453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiproliferative and antiviral activity of 2'-deoxy-2'-fluoroarabinofuranosyl analogs of the nucleoside antibiotics toyocamycin and sangivamycin.
    Krawczyk SH; Nassiri MR; Kucera LS; Kern ER; Ptak RG; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1995 Sep; 38(20):4106-14. PubMed ID: 7562946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine.
    Smith SH; Shipman C; Drach JC
    Cancer Res; 1978 Jul; 38(7):1916-21. PubMed ID: 207416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
    Renau TE; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1996 Feb; 39(4):873-80. PubMed ID: 8632411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
    Wakao K; Watanabe T; Takadama T; Ui S; Shigemi Z; Kagawa H; Higashi C; Ohga R; Taira T; Fujimuro M
    Biochem Biophys Res Commun; 2014 Feb; 444(2):135-40. PubMed ID: 24434142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proposed mechanism for the selective inhibition of human cytomegalovirus replication by 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-fluorouracil.
    Suzuki S; Misra HK; Wiebe LI; Knaus EE; Tyrrell DL
    Mol Pharmacol; 1987 Mar; 31(3):301-6. PubMed ID: 3031445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, cytotoxicity, and antiviral activity of certain 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidine nucleosides related to toyocamycin and sangivamycin.
    Gupta PK; Nassiri MR; Coleman LA; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1989 Jul; 32(7):1420-5. PubMed ID: 2500527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of acyclic halogenated tubercidin analogs against human cytomegalovirus and in uninfected cells.
    Nassiri MR; Turk SR; Birch GM; Coleman LA; Hudson JL; Pudlo JS; Townsend LB; Drach JC
    Antiviral Res; 1991 Sep; 16(2):135-50. PubMed ID: 1665958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activities of 2'-deoxyribofuranosyl and arabinofuranosyl analogs of sangivamycin against retro- and DNA viruses.
    Smee DF; McKernan PA; Alaghamandan HA; Frank KB; Ramasamy K; Revankar GR; Robins RK
    Antiviral Res; 1988 Dec; 10(6):263-77. PubMed ID: 2854957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of arabinosylthymine in herpesviral replication: mechanism of action in vivo and in vitro.
    Aswell JF; Allen GP; Jamieson AT; Campbell DE; Gentry GA
    Antimicrob Agents Chemother; 1977 Aug; 12(2):243-54. PubMed ID: 197886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor.
    Schwartz PM; Shipman C; Drach JC
    Antimicrob Agents Chemother; 1976 Jul; 10(1):64-74. PubMed ID: 185947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential inhibition of 5-trifluoromethyl-2'-deoxyuridine phosphorylation by 5'-amino-5'-deoxythymidine in uninfected versus herpes simplex virus-infected cells.
    Fischer PH; Murphy DG; Kawahara R
    Mol Pharmacol; 1983 Jul; 24(1):90-6. PubMed ID: 6408395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective growth inhibition by sangivamycin of human umbilical vein endothelial cells.
    Ohno O; Shima Y; Ikeda Y; Kondo SI; Kato K; Toi M; Umezawa K
    Int J Oncol; 2001 May; 18(5):1009-15. PubMed ID: 11295049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl-5-iodocytosine against human cytomegalovirus in human skin fibroblasts.
    Colacino JM; Lopez C
    Antimicrob Agents Chemother; 1985 Aug; 28(2):252-8. PubMed ID: 3010842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, cytotoxicity, and antiviral activity of some acyclic analogues of the pyrrolo[2,3-d]pyrimidine nucleoside antibiotics tubercidin, toyocamycin, and sangivamycin.
    Gupta PK; Daunert S; Nassiri MR; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1989 Feb; 32(2):402-8. PubMed ID: 2913300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arabinofuranosylpyrrolo[2,3-d]pyrimidines as potential agents for human cytomegalovirus infections.
    Krawczyk SH; Bernier-Rodriguez M; Nassiri MR; Kern ER; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1990 Dec; 33(12):3160-9. PubMed ID: 2175356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and studies on the structure activity relationships of certain pyrrolo[2,3-d]pyrimidine nucleosides and structurally related analogs as potential antineoplastic and antiviral agents.
    Townsend LB; Drach JC; Wotring LL; Vittori S; Pudlo JS; Swayze EE; Gupta P; Maruyama T; Saxena N; Coleman LA
    Farmaco; 1991 Jan; 46(1 Suppl):113-39. PubMed ID: 1649609
    [No Abstract]   [Full Text] [Related]  

  • 20. Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C.
    Loomis CR; Bell RM
    J Biol Chem; 1988 Feb; 263(4):1682-92. PubMed ID: 3338987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.